UGDH

UDP-glucose 6-dehydrogenase · O60701 · UGDH on Sugi Atlas →

0 patent compounds predicted against UGDH, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UGDH by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy PHASE4COMPLETED
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment - Part II PHASE4COMPLETED
Genetic Determinants of Amitriptyline Efficiency for Pain Treatment PHASE4COMPLETED
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) PHASE4UNKNOWN
Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN) PHASE1/PHASE2RECRUITING
First-in-human Study of UX016 in GNEM PHASE1/PHASE2NOT_YET_RECRUITING
Hydroxychloroquine Administration for Reduction of Pexophagy PHASE2COMPLETED
Pharmacokinetic Interaction Study of Efavirenz and American Ginseng in Healthy Volunteers PHASE1COMPLETED
Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors PHASE1COMPLETED
Gemcitabine With Ascorbate Including Adolescents EARLY_PHASE1WITHDRAWN
Glycosylation in Patients With Galactosaemia nanCOMPLETED
Intervention and Outcomes in Duarte Galactosemia nanCOMPLETED
Chronic Liver Disease in Urea Cycle Disorders nanCOMPLETED
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer nanCOMPLETED
Dose-response Effect of Alcohol Ingestion on Steroid Profile nanCOMPLETED
Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children nanRECRUITING
Liver Disease in Urea Cycle Disorders nanACTIVE_NOT_RECRUITING
Pharmacogenetic Study in Patients Received Iron Chelating Agent nanCOMPLETED
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study) nanCOMPLETED
PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia nanNOT_YET_RECRUITING
Individualized Antiretroviral Therapy nanCOMPLETED
Hepatic Histopathology in Urea Cycle Disorders nanRECRUITING
Evaluation of Blood Protein O-GlcNAcylation Levels in Children nanRECRUITING
Pharmacogenetic Determinants Of Treatment Response In Children nanRECRUITING
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation nanCOMPLETED
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network nanRECRUITING
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors nanCOMPLETED
Biomarker for Gilbert Disease (BioGilbert) nanWITHDRAWN
Pharmacogenetic and Neurofunctional Brain Areas Study in Obese Patients With Binge Eating Disorder nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a UGDH binder may also engage these)

ProteinNameSimilarity
Q5R7B3 1.000 Q5R7B3 →
O70475 1.000 O70475 →
Q9FZE1 1.000 Q9FZE1 →
Q5F3T9 1.000 Q5F3T9 →
O70199 1.000 O70199 →
P12378 0.999 P12378 →
O02373 0.996 O02373 →
Q19905 0.995 Q19905 →
Q9LF33 0.994 Q9LF33 →
Q9FM01 0.992 Q9FM01 →
Q96558 0.991 Q96558 →
Q9LIA8 0.989 Q9LIA8 →
Q9AUV6 0.989 Q9AUV6 →
Q2QS13 0.989 Q2QS13 →
Q2QS14 0.988 Q2QS14 →
B7F958 0.988 B7F958 →
P51585 0.987 P51585 →
Q75GS4 0.987 Q75GS4 →
Q5R5M8 0.984 Q5R5M8 →
Q88NC4 0.983 Q88NC4 →
Q887P8 0.982 Q887P8 →
Q5WE04 0.982 Q5WE04 →
Q5QKR8 0.982 Q5QKR8 →
Q9LPG6 0.982 Q9LPG6 →
O07299 0.982 O07299 →
P59793 0.981 P59793 →
Q0TUR4 0.981 Q0TUR4 →
P46586 0.981 P46586 →
P46487 0.981 P46487 →
Q9SCX9 0.981 Q9SCX9 →